282 related articles for article (PubMed ID: 34263179)
21. Mapping H4K20me3 onto the chromatin landscape of senescent cells indicates a function in control of cell senescence and tumor suppression through preservation of genetic and epigenetic stability.
Nelson DM; Jaber-Hijazi F; Cole JJ; Robertson NA; Pawlikowski JS; Norris KT; Criscione SW; Pchelintsev NA; Piscitello D; Stong N; Rai TS; McBryan T; Otte GL; Nixon C; Clark W; Riethman H; Wu H; Schotta G; Garcia BA; Neretti N; Baird DM; Berger SL; Adams PD
Genome Biol; 2016 Jul; 17(1):158. PubMed ID: 27457071
[TBL] [Abstract][Full Text] [Related]
22. Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer.
Mori JO; Elhussin I; Brennen WN; Graham MK; Lotan TL; Yates CC; De Marzo AM; Denmeade SR; Yegnasubramanian S; Nelson WG; Denis GV; Platz EA; Meeker AK; Heaphy CM
Nat Rev Urol; 2024 May; 21(5):258-273. PubMed ID: 37907729
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic Regulation of Cellular Senescence.
Crouch J; Shvedova M; Thanapaul RJRS; Botchkarev V; Roh D
Cells; 2022 Feb; 11(4):. PubMed ID: 35203320
[TBL] [Abstract][Full Text] [Related]
24. Cellular senescence and senescence-associated secretory phenotype via the cGAS-STING signaling pathway in cancer.
Loo TM; Miyata K; Tanaka Y; Takahashi A
Cancer Sci; 2020 Feb; 111(2):304-311. PubMed ID: 31799772
[TBL] [Abstract][Full Text] [Related]
25. Macrophages and tumor-associated macrophages in the senescent microenvironment: From immunosuppressive TME to targeted tumor therapy.
Du M; Sun L; Guo J; Lv H
Pharmacol Res; 2024 Jun; 204():107198. PubMed ID: 38692466
[TBL] [Abstract][Full Text] [Related]
26. Elimination of Radiation-Induced Senescence in the Brain Tumor Microenvironment Attenuates Glioblastoma Recurrence.
Fletcher-Sananikone E; Kanji S; Tomimatsu N; Di Cristofaro LFM; Kollipara RK; Saha D; Floyd JR; Sung P; Hromas R; Burns TC; Kittler R; Habib AA; Mukherjee B; Burma S
Cancer Res; 2021 Dec; 81(23):5935-5947. PubMed ID: 34580063
[TBL] [Abstract][Full Text] [Related]
27. Cellular senescence and the tumour microenvironment.
Takasugi M; Yoshida Y; Ohtani N
Mol Oncol; 2022 Sep; 16(18):3333-3351. PubMed ID: 35674109
[TBL] [Abstract][Full Text] [Related]
28. Senescence Can Be BETter without the SASP?
Vizioli MG; Adams PD
Cancer Discov; 2016 Jun; 6(6):576-8. PubMed ID: 27261480
[TBL] [Abstract][Full Text] [Related]
29. Role of Histone Variant H2A.J in Fine-Tuning Chromatin Organization for the Establishment of Ionizing Radiation-Induced Senescence.
Abd Al-Razaq MA; Freyter BM; Isermann A; Tewary G; Mangelinck A; Mann C; Rübe CE
Cells; 2023 Mar; 12(6):. PubMed ID: 36980257
[TBL] [Abstract][Full Text] [Related]
30. Cytoplasmic chromatin fragments-from mechanisms to therapeutic potential.
Miller KN; Dasgupta N; Liu T; Adams PD; Vizioli MG
Elife; 2021 Jan; 10():. PubMed ID: 33512316
[TBL] [Abstract][Full Text] [Related]
31. Targeting epiregulin in the treatment-damaged tumor microenvironment restrains therapeutic resistance.
Wang C; Long Q; Fu Q; Xu Q; Fu D; Li Y; Gao L; Guo J; Zhang X; Lam EW; Campisi J; Sun Y
Oncogene; 2022 Nov; 41(45):4941-4959. PubMed ID: 36202915
[TBL] [Abstract][Full Text] [Related]
32. Assessing Functional Roles of the Senescence-Associated Secretory Phenotype (SASP).
Malaquin N; Tu V; Rodier F
Methods Mol Biol; 2019; 1896():45-55. PubMed ID: 30474839
[TBL] [Abstract][Full Text] [Related]
33. Isolation methodology is essential to the evaluation of the extracellular vesicle component of the senescence-associated secretory phenotype.
Wallis R; Josipovic N; Mizen H; Robles-Tenorio A; Tyler EJ; Papantonis A; Bishop CL
J Extracell Vesicles; 2021 Feb; 10(4):e12041. PubMed ID: 33659050
[TBL] [Abstract][Full Text] [Related]
34. Melatonin regulates PARP1 to control the senescence-associated secretory phenotype (SASP) in human fetal lung fibroblast cells.
Yu S; Wang X; Geng P; Tang X; Xiang L; Lu X; Li J; Ruan Z; Chen J; Xie G; Wang Z; Ou J; Peng Y; Luo X; Zhang X; Dong Y; Pang X; Miao H; Chen H; Liang H
J Pineal Res; 2017 Aug; 63(1):. PubMed ID: 28247536
[TBL] [Abstract][Full Text] [Related]
35. Senescent cells in cancer therapy: why and how to remove them.
Zhang JW; Zhang D; Yu BP
Cancer Lett; 2021 Nov; 520():68-79. PubMed ID: 34237406
[TBL] [Abstract][Full Text] [Related]
36. The NSD2/WHSC1/MMSET methyltransferase prevents cellular senescence-associated epigenomic remodeling.
Tanaka H; Igata T; Etoh K; Koga T; Takebayashi SI; Nakao M
Aging Cell; 2020 Jul; 19(7):e13173. PubMed ID: 32573059
[TBL] [Abstract][Full Text] [Related]
37. Rutin is a potent senomorphic agent to target senescent cells and can improve chemotherapeutic efficacy.
Liu H; Xu Q; Wufuer H; Li Z; Sun R; Jiang Z; Dou X; Fu Q; Campisi J; Sun Y
Aging Cell; 2024 Jan; 23(1):e13921. PubMed ID: 37475161
[TBL] [Abstract][Full Text] [Related]
38. The impact of cellular senescence and senescence‑associated secretory phenotype in cancer‑associated fibroblasts on the malignancy of pancreatic cancer.
Higashiguchi M; Murakami H; Akita H; Kobayashi S; Takahama S; Iwagami Y; Yamada D; Tomimaru Y; Noda T; Gotoh K; Doki Y; Yamamoto T; Eguchi H
Oncol Rep; 2023 May; 49(5):. PubMed ID: 36999632
[TBL] [Abstract][Full Text] [Related]
39. The mechanotransduction of MLO-Y4 cells is disrupted by the senescence-associated secretory phenotype of neighboring cells.
Gardinier JD; Chougule A; Zhang C
J Cell Physiol; 2022 Apr; 237(4):2249-2257. PubMed ID: 35102547
[TBL] [Abstract][Full Text] [Related]
40. Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity.
Chien Y; Scuoppo C; Wang X; Fang X; Balgley B; Bolden JE; Premsrirut P; Luo W; Chicas A; Lee CS; Kogan SC; Lowe SW
Genes Dev; 2011 Oct; 25(20):2125-36. PubMed ID: 21979375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
